ACAvani A. Chopra

Avani A. Chopra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Avani A. Chopra has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Early vs Delayed Fixation and Systemic Complications in Geriatric Ankle Fractures: A Retrospective Cohort Study

    by Dhruv Mendiratta, Halyn Xheraj, Priyanka Mehta, Shriyaus Lingam, Avani Chopra, Gnaneswar Chundi, Abhiram Dawar, Constantine Sedereas, David Reiter, Michael Aynardi, et al.

    Background: The optimal operative timing for geriatric ankle fractures remains controversial, particularly in patients with significant comorbidities. Although delayed fixation may allow for medical optimization, its association with postoperative systemic complications is not well defined. Methods: A retrospective cohort study was performed using the Nationwide Readmissions Database (2016-2021). Patients aged 65 years and older undergoing open reduction and internal fixation for bimalleolar or trimalleolar ankle fractures were identified. Patients were stratified by operative timing into early (≤2 days) and delayed (>2 days) fixation groups. Propensity score matching was used to balance baseline characteristics. Postoperative medical complications, in-hospital mortality, length of stay, and readmission rates were compared between groups. Results: A total of 73 956 patients met inclusion criteria, with 61 829 undergoing early fixation and 12 127 undergoing delayed fixation. In the matched cohort, delayed fixation was associated with higher rates of sepsis (4.1% vs 1.0%, P < .001), pneumonia (5.3% vs 1.8%, P < .001), acute kidney failure (23.8% vs 13.3%, P < .001), acute heart failure (3.9% vs 1.3%, P < .001), atrial fibrillation (18.8% vs 13.8%, P < .001), and urinary tract infection (14.7% vs 8.2%, P < .001). In-hospital mortality was higher in the delayed fixation group (1.3% vs 0.6%, P = .002). With the numbers available, no significant difference could be detected in rates of pulmonary embolism or deep vein thrombosis ( P = .417). Delayed fixation was also associated with increased length of stay (10.13 days vs 4.71 days, P < .001). Conclusion: In a propensity-matched cohort of geriatric patients, delayed operative fixation of ankle fractures was associated with systemic medical complications, prolonged hospitalization, and higher in-hospital mortality. These findings should be interpreted as hypothesis-generating associations, as causation cannot be established and the observed associations may reflect underlying clinical complexity of patients requiring delayed intervention. Level of Evidence: Level III, retrospective cohort study.

  • Open Access

    A Break-Even Cost-effectiveness Analysis for Venous Thromboembolism Prophylaxis in Achilles Tendon Repair Surgery

    by Kush Mody, Avani A. Chopra, David Ahn, Iyad S. Ali, Michael C. Aynardi, Sheldon Lin

    Background. Venous thromboembolism (VTE) is a potentially life-threatening complication following orthopaedic surgery. While prophylaxis is well-established in joint arthroplasty, its role after Achilles tendon repair remains controversial. Despite being a soft-tissue procedure, prolonged postoperative immobilization increases VTE risk, with some studies reporting symptomatic rates as high as 7%. However, no prior studies have assessed whether pharmacologic VTE prophylaxis breaks-even in this population. Methods. A literature review and the TriNetX Research Network were used to identify symptomatic VTE rates within 30 days of primary Achilles tendon repair without pharmacologic prophylaxis. The cost of treating a symptomatic VTE was estimated from published data and adjusted to 2025 US dollars. Retail drug pricing was obtained from an online pharmacy database. A break-even analysis was conducted to determine the absolute risk reduction (ARR) and number needed to treat (NNT) required for aspirin (81 mg and 325 mg), warfarin (5 mg), enoxaparin (40 mg), and rivaroxaban (20 mg) to be cost-effective. A sub-analysis compared postoperative bleeding and transfusion rates in patients who received chemoprophylaxis versus those who did not. Results. Among 8935 patients undergoing Achilles tendon repair without chemoprophylaxis, 47 developed a symptomatic VTE (0.526%). Aspirin and warfarin broke-even across all VTE rates, with NNTs ranging from 9217 to 10 547. Warfarin still broke-even when including international normalized ratio (INR) monitoring costs. Enoxaparin and rivaroxaban only broke-even at the highest VTE rate (7.2%), with NNTs of 131 and 390, respectively, and required higher VTE treatment costs to be justified. Conclusion. In this study, we found that aspirin 81 mg, aspirin 325 mg, and warfarin break-even for VTE chemoprophylaxis following Achilles tendon repair. Enoxaparin and rivaroxaban failed to break-even. Chemoprophylaxis decisions should be individualized, weighing patient risk and economic considerations.

  • Open Access

    Comparative outcomes of autograft versus rhPDGF-BB in rearfoot and ankle arthrodesis: A propensity-matched TriNetX analysis

    by David Ahn, Avani Chopra, Abhiram Dawar, Gnaneswar Chundi, Tuckerman Jones, Zachary Fuller, Mark Fisher, Scott Tucker, Michael Aynardi, Sheldon S. Lin

  • Open Access

    Complication rates in open versus arthroscopic ankle arthrodesis in patients with avascular necrosis of the talus

    by Avani A. Chopra, Daniella Ogilvie, Michael Greenberg, Darian Napoleon, Tuckerman Jones, David Ahn, Abhiram Dawar, Gnaneswar Chundi, Scott Tucker, Sheldon Lin, et al.

  • Open Access

    Impact of preoperative cannabis use on short and mid-term postoperative outcomes following total hip and knee arthroplasty

    by Zachary Fuller, Shriyaus Lingam, Avani Chopra, Jeremiah Thomas, Jorden Urias, Zuhdi E. Abdo


  • Open Access

    Impact of Prior Ipsilateral Arthrodesis on Subsequent Ankle and Subtalar Fusion Outcomes: A Propensity-Matched Cohort Study

    by Avani A. Chopra, Kush Mody, Mark Fisher, David Ahn, Gnaneswar Chundi, Abhiram Dawar, Tuckerman Jones, Scott Tucker, Sheldon Lin, Michael Aynardi

    Background: Although prior ankle or subtalar arthrodesis is thought to affect outcomes at adjacent joints, previous studies have not distinguished between successful and failed prior fusions. This study examines whether prior successful vs failed ipsilateral arthrodesis influences nonunion risk in subsequent ankle or subtalar fusion. The primary objective of this study is to examine nonunion rates after subtalar and ankle arthrodesis in patients with and without prior ipsilateral arthrodesis, and vice versa. Methods: A retrospective study using the TriNetX Research Network compared nonunion rates in patients who underwent subtalar (ST) arthrodesis with (ankle-ST) or without (ST-only) prior ankle arthrodesis. Patients were stratified by whether the prior arthrodesis was successful (no nonunion diagnosis/revision) or failed (nonunion requiring revision Ankle-ST patients were stratified by successful or failed prior ankle arthrodesis. A secondary analysis evaluated ankle arthrodesis in patients with (ST-ankle) or without (ankle-only) prior subtalar arthrodesis, similarly stratified. Propensity score matching (1:1) adjusted for age, sex, body mass index (BMI), and comorbidities. The primary outcome is nonunion rates. Results: 144 patients were in the successful ankle-ST cohort and 12,635 in the ST-only cohort. After propensity score matching, successful ankle-ST patients had no difference in nonunion rates (16.7% vs 16.0%, P = .873). However, patients with failed prior ankle arthrodesis had a 3-fold higher risk of subtalar nonunion compared to those with successful ankle fusion (risk ratio [RR] 3.0, 95% CI 1.79-5.02). Furthermore, 109 patients were in the successful ST-Ankle group and 6,801 in the ankle-only group. After matching, there was no difference in rate of nonunion (11.1% vs 19.4%, P = .089) between the successful ST-ankle and the ankle-only groups. Conversely, patients with failed prior subtalar arthrodesis had a 2.4-fold higher risk of ankle nonunion compared to those with successful subtalar fusion (RR 2.4, 95% CI 1.30-4.42). Conclusion: Our analysis of the TriNetX Research Network database suggests that when the primary ankle or subtalar arthrodesis is successful, performing a subsequent adjacent fusion does not significantly increase the risk of nonunion compared with an isolated fusion. However, failed prior arthrodesis substantially increases nonunion risk, highlighting the importance of distinguishing between successful and failed prior procedures in clinical decision-making.


  • Open Access

    Antiphospholipid Syndrome in Orthopaedic Foot and Ankle Surgery: A Propensity-Matched Analysis

    by Kush Mody, Avani A. Chopra, Michael Greenberg, Darian Napoleon, Tyler Stewart, Michael Aynardi, Sheldon Lin

    Background: Antiphospholipid syndrome (APS) is a systemic autoimmune disorder associated with a heightened risk of thromboembolic events. The purpose of this study is to evaluate the impact of APS on medical and surgical postoperative outcomes following foot and ankle surgery. Methods: Using the TriNetX Research Network, we identified patients undergoing foot and ankle surgery between 2004 and 2024. APS patients with and without postoperative venous thromboembolism (VTE) prophylaxis were matched 1:1 with controls based on demographics and comorbidities. Outcomes within 30 and 90 days postoperatively were compared, including thromboembolic events. Preoperative laboratory test values were also assessed in a subset of APS patients not on anticoagulation. Results: At 90 days postoperatively, APS patients receiving VTE prophylaxis (APS+VTE) (n = 524) had significantly higher rates of deep vein thrombosis (13.4% vs 9.0%, P = .024), but similar rates of stroke and pulmonary embolism compared to patients without APS receiving VTE prophylaxis (Control+VTE). Anemia was significantly less common in the APS+VTE group at 30 days (14.7% vs 22.3%, P = .001) and 90 days (16.4% vs 23.9%, P = .003). APS patients without postoperative anticoagulation (APS–VTE) (n = 932) had a higher rate of pulmonary embolism at 90 days (5.8% vs 3.3%, P = .011) compared to patients without APS and VTE prophylaxis (Control–VTE). Anticoagulation-naïve APS patients demonstrated significantly higher preoperative International Normalized Ratio (1.64 vs 1.09, P < .001), prothrombin time (17.7 vs 12.3, P < .001), activated partial thromboplastin time (38.6 vs 29.2, P < .001), serum creatinine (1.08 vs 0.94, P < .001), estimated dry weight (14.3 vs 13.7, P < .001), along with urea nitrogen (17.0 vs 15.9, P < .001), sodium (139.13 vs 139.25, P = .001), potassium (4.14 vs 4.10, P = .012), and bicarbonate (26.2 vs 25.8, P < .001) compared with matched controls. Conclusion: APS patients undergoing foot and ankle surgery had significantly higher thromboembolic event rates than controls, even with anticoagulation, and those who received anticoagulation had lower anemia rates, suggesting differential bleeding risk. Level of Evidence: Level III, retrospective cohort study.

  • Open Access

    Intramedullary Nailing vs Plate Fixation of the Fibula in the Setting of Distal Tibial Fractures Requiring ORIF: National Readmissions Database Propensity Score–Matched Analysis

    by Gnaneswar Chundi, Abhiram Dawar, Ian Briggs, David B. Ahn, Avani A. Chopra, Zachary Fuller, Sheldon S. Lin, Tuckerman Jones

    Background: Most cases of tibia and fibula shaft fractures are treated without fixation of the fibula. However, there are some cases where fibula fixation is thought to improve patient outcome. The fibula can be stabilized by surface plating or medullary nailing but literature comparing these 2 fixation techniques is limited. This study evaluates postoperative complications and readmission rates between intramedullary (IM) nailing and surface plating of fibular fractures in patients undergoing concomitant tibial osteosynthesis. Methods: Using the Nationwide Readmissions Database (NRD) from 2016 to 2021, we identified patients undergoing tibial open reduction and internal fixation (ORIF) for distal tibial fractures with concurrent fibular fixation using either IM nailing or plate fixation were identified. Propensity score matching was performed to balance demographic and clinical covariates. The prespecified primary endpoint was overall 90-day wound/infectious complications; secondary outcomes included specific complications and 30- and 90-day readmissions. Results: After matching, 3497 IM nailing cases and 3381 plating cases were included. Baseline characteristics were similar between groups. IM fixation was associated with significantly lower rates of overall complications (7.5% vs 9.8%, P = .001), wound dehiscence (0.6% vs 1.8%, P < .001), infection (1.3% vs 2.8%, P < .001), malunion (0.4% vs 0.9%, P = .018), and abscess formation (0.1% vs 0.4%, P = .039). Although 30-day and total readmission rates were similar, the plate fixation group had significantly higher rates of infection- and wound-related readmissions. Conclusion: In patients undergoing tibial ORIF for distal tibial fractures, adjunctive fibular IM nailing is associated with fewer wound-related complications and infections compared with plate fixation, without compromising union or readmission rates. IM nailing may be a lower-morbidity alternative for selected patients, pending prospective studies that incorporate fracture morphology and functional outcomes. Level of Evidence: Level III, prognostic.

  • Open Access

    Impact of Local Vancomycin on Postoperative Outcomes in Ankle Arthrodesis: A Propensity-Matched Cohort Study

    by Avani A. Chopra, Tuckerman Jones, Abhiram Dawar, Gnaneswar Chundi, David Ahn, Jonathan Lopez, Scott Tucker, Sheldon Lin, Michael Aynardi

    Introduction: In orthopaedic surgery, intrawound vancomycin has become a widely used strategy to reduce the incidence of surgical site infections, commonly caused by gram-positive microorganisms. This study evaluated the incidence of postoperative orthopaedic complications in patients undergoing ankle arthrodesis with and without the use of intrawound vancomycin. Methods: This retrospective study used data from the TriNetX Research Network to identify patients who underwent ankle arthrodesis between October 1, 2002, and October 1, 2022. This population was divided into two cohorts: patients who received perioperative cefazolin and local vancomycin (cefazolin-vancomycin) and patients who received perioperative cefazolin but no local vancomycin (cefazolin-only). This study assessed rates of implant-related complications occurring within 2 years of the arthrodesis. Results: A total of 374 patients in the cefazolin-vancomycin cohort and 5,218 in the cefazolin-only cohort were identified, with an average age of 58.0 ± 14.0 years and 56.6 ± 14.6 years, respectively ( P = 0.083). Before matching, the cefazolin-vancomycin cohort had higher rates of comorbidities, including diabetes (30% vs. 21%, P < 0.001), obesity (32% vs. 21%, P < 0.001), and liver disease (13% vs. 5%, P < 0.001). After propensity matching, each cohort had 373 patients. The cefazolin-vancomycin group demonstrated a significantly lower risk of nonunion (13% vs. 19%, P = 0.020), whereas other outcomes showed no statistically significant differences. Conclusion: This study evaluated the incidence of postoperative complications in patients undergoing ankle arthrodesis with and without intrawound vancomycin. The analysis demonstrated a markedly lower nonunion rate in the cefazolin-vancomycin group (13%) compared with the cefazolin-only group (19%), aligning with previously reported rates but lower than those seen in high-risk populations. These findings suggest that local vancomycin administration may mitigate nonunion risk and optimize fusion outcomes in ankle arthrodesis by reducing infection.


  • Open Access

    Three-Dimensional Assessment of Charcot Neuroarthropathy Deformities: Comparison of Standard 2D vs Patient-Specific 3D Measurements

    by Avani A. Chopra, Zachary Adam Koroneos, Michaela D. Pitcher, Christian Benedict, Peter Tortora, Taylor Lan, Michael Levidy, Allen Kunselman, Michael Aynardi

    Background: The purpose of this study is to compare foot and ankle deformity measurements obtained from 2-dimensional (2D) radiographs vs 3-dimensional (3D) modalities in Charcot neuroarthropathy (CN) feet by using a patient-specific coordinate system. Methods: This retrospective study reviewed foot and ankle imaging for 25 patients with a diagnosis of CN of the lower extremity, type 2 diabetes mellitus with diabetic neuropathy, or lower limb neuropathy. Radiographs and either computed tomography (CT) or magnetic resonance imaging (MRI) scans were obtained for each patient and used to make angle and distance measurements used clinically to describe deformity. 2D measurements were obtained using standard methods, involving annotating planar radiographs. The 3D measurement procedure began by manually placing fiducials on anatomic landmarks. Then, a custom-built code was used to automatically transform the foot into a patient-specific anatomic coordinate system and calculate all angle and distance measurements. Each scan was measured by 2 observers and intraclass correlation was calculated for each imaging type. Results: The average age of the patients was 61 years, with 92% being White and 88% having diabetic neuroarthropathy. Measurements for anteroposterior talocalcaneal angle and lateral column height were larger when measured on MRI (91.1 ± 16.7 degrees vs 29.1 ± 2.8 degrees, P = .004) and CT (78.6 ± 18.5 degrees vs 24.6 ± 2.7 degrees, P = .020) compared with radiographic measurements. Additionally, MRI demonstrated significantly greater interobserver reliability for the talocalcaneal angle (0.74 vs 0.19, 95% CI 0.11, 0.96), suggesting improved detection of hindfoot valgus compared with radiographs, whereas CT reliability was comparable to plain radiographs. Conclusion: Larger measurements and higher interobserver reliability for the talocalcaneal angle on 3D modalities suggest that a patient-specific 3D approach may improve detection of transverse-plane malalignment in Charcot neuroarthropathy.